Stocks and Investing Stocks and Investing
Thu, February 25, 2021
Wed, February 24, 2021
Tue, February 23, 2021
Mon, February 22, 2021

Etzer Darout Downgraded (ALNY) to Hold and Held Target at $162 on, Feb 22nd, 2021


Published on 2024-10-27 15:43:40 - WOPRAI
  Print publication without navigation


Etzer Darout of Guggenheim, Downgraded "Alnylam Pharmaceuticals, Inc." (ALNY) to Hold and Held Target at $162 on, Feb 22nd, 2021.

Etzer has made no other calls on ALNY in the last 4 months.



There are 7 other peers that have a rating on ALNY. Out of the 7 peers that are also analyzing ALNY, 3 agree with Etzer's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Joel Beatty of "Citigroup" Downgraded from Strong Buy to Hold and Increased Target to $175 on, Friday, February 12th, 2021
  • Do Kim of "BMO Capital" Downgraded from Buy to Hold and Held Target at $185 on, Monday, January 25th, 2021
  • Mani Foroohar of "SVB Leerink" Maintained at Hold with Increased Target to $93 on, Wednesday, November 25th, 2020


These are the ratings of the 4 analyists that currently disagree with Etzer


  • Gena Wang of "Barclays" Maintained at Buy with Increased Target to $196 on, Friday, February 12th, 2021
  • Joseph Stringer of "Needham" Maintained at Strong Buy with Increased Target to $180 on, Friday, February 12th, 2021
  • David Lebovitz of "Morgan Stanley" Maintained at Buy with Increased Target to $206 on, Friday, February 12th, 2021
  • Patrick Trucchio of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $235 on, Friday, February 12th, 2021